home *** CD-ROM | disk | FTP | other *** search
- TABLE 45.5-7. Representative Treatment Regimens in Myelodysplastic
- Syndromes
-
- IDR/A, idarubicin/cytarabine; FLAG, fludarabine, cytarabine; LoDAC,
- low dose cytarabine; HHT, homoharringtonine; HMBA, hexamethylene
- bisacetamide; 5-Aza, 5-azacytidine; AlloBMT, allogeneic bone marrow
- transplant; Bu/Cy, busulfan/cyclophosphamide; DFS, disease-free
- survival; CR, complete remission.
- *Includes patients with secondary AML.
-